Literature DB >> 19158493

p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage.

Laura D Gillis1, Andrew M Leidal, Richard Hill, Patrick W K Lee.   

Abstract

p21(Cip1/WAF1) is the principle mediator of cell cycle arrest in response to DNA damage. p21 primarily mediates G(1) cell cycle arrest by inactivating G(1)-associated cyclin A- and cyclin E-containing cyclin/cdk complexes. In the present study we investigate the role of p21 in DNA damage-induced G(2) cell cycle arrest, particularly with respect to the G(2)-associated cyclin, cyclin B1. We demonstrate that cells lacking p21 or deficient in their ability to upregulate p21 are unable to mediate the downregulation of cyclin B1 in response to DNA damage as compared to wild-type cells. Decreased levels of cyclin B1 in response to DNA damage seen in wild-type cells is due to p21-mediated degradation of cyclin B1 as this can be inhibited by a proteasomal inhibitor. Cell cycle analysis reveals that p21-null cells are unable sustain G(2) cell cycle arrest and accumulate at greater than 4N DNA content. These results indicate that p21-mediated degradation of cyclin B1 in response to DNA damage is necessary for the maintenance of G(2) cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158493     DOI: 10.4161/cc.8.2.7550

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

Review 1.  Senescence from G2 arrest, revisited.

Authors:  Véronique Gire; Vjekoslav Dulic
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Long non-coding RNA slincRAD functions in methylation regulation during the early stage of mouse adipogenesis.

Authors:  Fan Yi; Pei Zhang; Yao Wang; Yin Xu; Zhengxi Zhang; Weizhi Ma; Bo Xu; Qing Xia; Quan Du
Journal:  RNA Biol       Date:  2019-06-19       Impact factor: 4.652

3.  The ETS family transcription factor ELK-1 regulates induction of the cell cycle-regulatory gene p21(Waf1/Cip1) and the BAX gene in sodium arsenite-exposed human keratinocyte HaCaT cells.

Authors:  Soon Young Shin; Chang Gun Kim; Yoongho Lim; Young Han Lee
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

4.  Carotid body growth during chronic postnatal hyperoxia.

Authors:  Elizabeth F Dmitrieff; Samantha E Piro; Thomas A Broge; Kyle B Dunmire; Ryan W Bavis
Journal:  Respir Physiol Neurobiol       Date:  2011-11-22       Impact factor: 1.931

5.  Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells.

Authors:  Samiha Mateen; Komal Raina; Anil K Jain; Chapla Agarwal; Daniel Chan; Rajesh Agarwal
Journal:  Epigenetics       Date:  2012-09-10       Impact factor: 4.528

6.  Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status.

Authors:  Hesham M Hassan; Michelle L Varney; Nagendra K Chaturvedi; Shantaram S Joshi; Dennis D Weisenburger; Rakesh K Singh; Bhavana J Dave
Journal:  Leuk Lymphoma       Date:  2016-04-13

7.  RB deletion disrupts coordination between DNA replication licensing and mitotic entry in vivo.

Authors:  Ryan J Bourgo; Ursula Ehmer; Julien Sage; Erik S Knudsen
Journal:  Mol Biol Cell       Date:  2011-02-02       Impact factor: 4.138

8.  EAPP modulates the activity of p21 and Chk2.

Authors:  Peter Andorfer; Ludwig Schwarzmayr; Hans Rotheneder
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

9.  Osmotic pressure modulates single cell cycle dynamics inducing reversible growth arrest and reactivation of human metastatic cells.

Authors:  Hubert M Taïeb; Daniela S Garske; Jörg Contzen; Manfred Gossen; Luca Bertinetti; Tom Robinson; Amaia Cipitria
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

Review 10.  New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy.

Authors:  Razmik Mirzayans; Bonnie Andrais; April Scott; David Murray
Journal:  J Biomed Biotechnol       Date:  2012-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.